Shares in telehealth business Hims & Hers Health (HIMS) dropped over 6% today after reports that it and peers are marketing ...

While needing a “prescription” for these might sound intimidating, the process to work with their medical team is actually rather simple. Hims team ... a preference of pill vs topical solution ...

Hims is a telemedicine platform that ... Chewable PDE5 inhibitors work just like regular ED pills that you swallow. The main difference is the way that they’re consumed and the speed at ...

Hims and Roman are telehealth companies that sell prescription and nonprescription products to treat erectile dysfunction (ED), hair loss, and premature ejaculation (PE). Both ED and hair loss can ...

Hims & Hers is set to continue offering weight-loss pills and personalized weight-loss support, including nutrition plans and coaching. Outside of weight-loss care, the company saw its subscriber ...

Hims & Hers (HIMS) made a killing last year selling ... 1 diabetes and weight-loss drugs Ozempic and Wegovy. These drugs work by mimicking a gut hormone that regulates blood sugar and suppress ...

Hims and Hers plans to stop selling compounded weight loss drugs after an FDA update. Hims and Hers' stock fell over 19% in after-hours trading on Monday. The FDA removed semaglutide injections ...

Hims & Hers (HIMS) stock plunged 27% on Tuesday after the telehealth highflier indicated it may soon stop offering some compounded versions of weight-loss drugs. The company's fourth quarter ...

Hims & Hers Health Inc. is expanding beyond its successful foray into providing copycat weight-loss drugs with the acquisition of a home blood-testing company. The telehealth provider purchased ...

Hims & Hers Health (NYSE:HIMS) shares were on a massive run, but that momentum hit a wall recently. Since its peak on ...